Cargando…

Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study

Background: Freezing of gait (FOG) could be partly alleviated by dopaminergic drugs but the mechanism still needs to be elucidated. The purpose of this study is to explore the mechanisms of FOG by vesicular monoamine transporter VMAT2 distribution with the (18)F-AV133 tracer and 18-fludeoxyglucose p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yongtao, Zhao, Junwu, Hou, Yaqin, Su, Yusheng, Chan, Piu, Wang, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645693/
https://www.ncbi.nlm.nih.gov/pubmed/31410003
http://dx.doi.org/10.2147/NDT.S197879
_version_ 1783437517126631424
author Zhou, Yongtao
Zhao, Junwu
Hou, Yaqin
Su, Yusheng
Chan, Piu
Wang, Yuping
author_facet Zhou, Yongtao
Zhao, Junwu
Hou, Yaqin
Su, Yusheng
Chan, Piu
Wang, Yuping
author_sort Zhou, Yongtao
collection PubMed
description Background: Freezing of gait (FOG) could be partly alleviated by dopaminergic drugs but the mechanism still needs to be elucidated. The purpose of this study is to explore the mechanisms of FOG by vesicular monoamine transporter VMAT2 distribution with the (18)F-AV133 tracer and 18-fludeoxyglucose positron emission tomography–computed tomography ((18)F-FDG PET-CT). Methods: Clinical material and PET-CT data were collected from 20 patients with FOG and 147 patients without FOG from November 1, 2017 to October 31, 2018. Brain scans of all participants were acquired over an approximately 20-min period, 120 min after injection of approximately 250 MBq (18)F-AV133. The mean uptake ratios of different regions were identified by NeuroQ software of (18)F-FDG PET-CT. Data analysis included variance, chi-square analysis, covariance analysis, and logistic regression. Results: Our data showed that patients with FOG were provided with greater doses of dopaminergic drugs (p<0.05). The frequency of FOG was 11.98% and increased as Parkinson’s disease progressed. FOG was more common in the elderly and strongly associated with the duration. Cognitive impairments were obvious, assessed by Mini-Mental State Examination and Montreal Cognitive Assessment (p<0.05). The VMAT2 distribution with (18)F-AV133 was decreased significantly in the caudate nucleus and lentiform nucleus while the metabolism of these areas was elevated, determined by (18)F-FDG PET-CT (p<0.05). The metabolism of the primary visual cortex decreased obviously in patients with FOG compared with those without FOG (p<0.05). Conclusion: FOG mainly occurred in the advanced stage, and was strongly associated with the duration and larger dose of dopaminergic drugs. The dopamine level of the nigrostriatal system decreased significantly and the uptake ratios of the primary visual cortex dropped obviously in the FOG group compared with the non-FOG group. Our study suggests that both the dopaminergic pathway and the primary visual cortex are involved in the pathogenesis of FOG.
format Online
Article
Text
id pubmed-6645693
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66456932019-08-13 Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study Zhou, Yongtao Zhao, Junwu Hou, Yaqin Su, Yusheng Chan, Piu Wang, Yuping Neuropsychiatr Dis Treat Original Research Background: Freezing of gait (FOG) could be partly alleviated by dopaminergic drugs but the mechanism still needs to be elucidated. The purpose of this study is to explore the mechanisms of FOG by vesicular monoamine transporter VMAT2 distribution with the (18)F-AV133 tracer and 18-fludeoxyglucose positron emission tomography–computed tomography ((18)F-FDG PET-CT). Methods: Clinical material and PET-CT data were collected from 20 patients with FOG and 147 patients without FOG from November 1, 2017 to October 31, 2018. Brain scans of all participants were acquired over an approximately 20-min period, 120 min after injection of approximately 250 MBq (18)F-AV133. The mean uptake ratios of different regions were identified by NeuroQ software of (18)F-FDG PET-CT. Data analysis included variance, chi-square analysis, covariance analysis, and logistic regression. Results: Our data showed that patients with FOG were provided with greater doses of dopaminergic drugs (p<0.05). The frequency of FOG was 11.98% and increased as Parkinson’s disease progressed. FOG was more common in the elderly and strongly associated with the duration. Cognitive impairments were obvious, assessed by Mini-Mental State Examination and Montreal Cognitive Assessment (p<0.05). The VMAT2 distribution with (18)F-AV133 was decreased significantly in the caudate nucleus and lentiform nucleus while the metabolism of these areas was elevated, determined by (18)F-FDG PET-CT (p<0.05). The metabolism of the primary visual cortex decreased obviously in patients with FOG compared with those without FOG (p<0.05). Conclusion: FOG mainly occurred in the advanced stage, and was strongly associated with the duration and larger dose of dopaminergic drugs. The dopamine level of the nigrostriatal system decreased significantly and the uptake ratios of the primary visual cortex dropped obviously in the FOG group compared with the non-FOG group. Our study suggests that both the dopaminergic pathway and the primary visual cortex are involved in the pathogenesis of FOG. Dove 2019-07-10 /pmc/articles/PMC6645693/ /pubmed/31410003 http://dx.doi.org/10.2147/NDT.S197879 Text en © 2019 Zhou et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhou, Yongtao
Zhao, Junwu
Hou, Yaqin
Su, Yusheng
Chan, Piu
Wang, Yuping
Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
title Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
title_full Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
title_fullStr Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
title_full_unstemmed Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
title_short Dopaminergic pathway and primary visual cortex are involved in the freezing of gait in Parkinson’s disease: a PET-CT study
title_sort dopaminergic pathway and primary visual cortex are involved in the freezing of gait in parkinson’s disease: a pet-ct study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645693/
https://www.ncbi.nlm.nih.gov/pubmed/31410003
http://dx.doi.org/10.2147/NDT.S197879
work_keys_str_mv AT zhouyongtao dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy
AT zhaojunwu dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy
AT houyaqin dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy
AT suyusheng dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy
AT chanpiu dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy
AT wangyuping dopaminergicpathwayandprimaryvisualcortexareinvolvedinthefreezingofgaitinparkinsonsdiseaseapetctstudy